Interview with Matthieu Accolas, General Manager, Servier Turkey
Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the generic penetration is much lower…
Liba was founded in 1945, receıving its name from its two founders, names: Lale and Necip Barlas. Lale Barlas was one of the first women pharmacists in Turkey, also teaching chemistry; Necip Barlas was a businessman, having studied economics.
They began their enterprise by making “cold tissues” in their apartment. Liba diversified its spectrum of products, and moved to Provayans Han in Tahtakale in 1946, then to Karaköy Perşembe Pazarı in 1948. In 1966 it received its status as an Incorporated Company, becoming Liba Laboratories Inc. The company then moved to Ortaköy Palanga Cad. in 1972, where it thrived for 22 years, and finally moved to its current building in Kavacık.
Today, Liba represents companies including Gerot Pharmazuetika, Alcon Pharmaceuticals (a Novartis company), Reckitt Benckiser, and others.
Liba Laboratuarları A.Ş.
Otağtepe Cad. No:5
Kavacık Anadoluhisarı,
İstanbul – Türkiye
Tel: +90 216 465 38 85
Fax: +90 216 465 38 80
info@liba.com.tr
Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the generic penetration is much lower…
Currently, what are the main priorities and goals of ISPAT related to the Healthcare and Pharmaceuticals sector, and what are the overall strategies designed to achieve these objectives? As an…
What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is always challenging…
Can you describe the current investment climate in Turkey for pharma companies? Turkey’s economic and political situation are very important factors to consider for foreign investors. Over the last three…
Mr. Ediz Günsel, could you introduce yourself to our readers ? Yes; I have been with the firm over twenty years, including 5 years with PwC London. In my twenty…
At Reckitt Benckiser, you have gradually taken positions of increasing responsibility over the last decade in Marketing. What would you highlight as the main specificities of Turkish market compared to…
The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General Manager of Ferring Turkey over those last 7 years. Can you…
Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it positions itself in…
You have pharmaceuticals production in your background and have recently joined PharmaVision as General Manager. To what extent does this speak about the company’s direction? Could you elaborate on your…
Mr Fadıllıoğlu, after a previous position at Abbott, you were recently appointed head of GSK Turkey. How different is GSK as an organization? What new therapeutic areas, processes, or corporate…
Mr Acar, could you present to our readers the Institution’s historical development and its role today in the Turkish pharmaceutical and healthcare sector? Before Social Security Reform was initiated, there…
Mr Yusuf, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. Having been instrumental in the formation of the…
See our Cookie Privacy Policy Here